rs148967240
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_144991.3(TSPEAR):c.418G>A(p.Ala140Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000227 in 1,612,380 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_144991.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TSPEAR | NM_144991.3 | c.418G>A | p.Ala140Thr | missense_variant | 3/12 | ENST00000323084.9 | NP_659428.2 | |
TSPEAR | NM_001272037.2 | c.214G>A | p.Ala72Thr | missense_variant | 4/13 | NP_001258966.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TSPEAR | ENST00000323084.9 | c.418G>A | p.Ala140Thr | missense_variant | 3/12 | 1 | NM_144991.3 | ENSP00000321987.4 | ||
TSPEAR | ENST00000397916.1 | n.373G>A | non_coding_transcript_exon_variant | 3/11 | 1 | |||||
TSPEAR | ENST00000642437.1 | n.*363G>A | non_coding_transcript_exon_variant | 4/13 | ENSP00000496535.1 | |||||
TSPEAR | ENST00000642437.1 | n.*363G>A | 3_prime_UTR_variant | 4/13 | ENSP00000496535.1 |
Frequencies
GnomAD3 genomes AF: 0.000401 AC: 61AN: 152128Hom.: 0 Cov.: 29
GnomAD3 exomes AF: 0.000470 AC: 116AN: 246908Hom.: 0 AF XY: 0.000297 AC XY: 40AN XY: 134650
GnomAD4 exome AF: 0.000209 AC: 305AN: 1460252Hom.: 1 Cov.: 32 AF XY: 0.000197 AC XY: 143AN XY: 726428
GnomAD4 genome AF: 0.000401 AC: 61AN: 152128Hom.: 0 Cov.: 29 AF XY: 0.000538 AC XY: 40AN XY: 74296
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 04, 2019 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2020 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 11, 2024 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jun 18, 2015 | Variant classified as Uncertain Significance - Favor Benign. The p.Ala140Thr var iant in TSPEAR has been previously reported by our laboratory in one individual with hearing loss, but a variant affecting the remaining copy of TSPEAR was not identified. This variant has been identified in 0.2% (26/11328) of Latino chrom osomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org ; dbSNP rs148967240). Although this variant has been seen in the general populat ion, its frequency is not high enough to rule out a pathogenic role. Computation al prediction tools and conservation analysis suggest that the p.Ala140Thr varia nt may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, while the clinical significance of the p. Ala140Thr variant is uncertain, these data suggest that it is more likely to be benign. - |
TSPEAR-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 17, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at